Author： Aaronson Colin
Publisher： Palgrave Macmillan Ltd
ISSN： 1478-565X
Source： Journal of Commercial Biotechnology, Vol.11, Iss.3, 2005-04, pp. : 289-291
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Serono International SA is one of the world's largest biotechnology companies with sales in 2004 of almost US2.5bn made in over 90 countries. The company presently has eight biotechnology products and operates in four market areas: neurology, reproductive health, growth and metabolism, and dermatology. Serono's shares are traded on the Swiss Exchange as well as the virt-x exchange and its American depositary receipts (ADRs) are traded on the New York Stock Exchange. Its results were released on 1st February, 2005. The company has its headquarters in Geneva.Journal of Commercial Biotechnology (2005) 11, 289–291; doi:10.1057/palgrave.jcb.3040129
Related content
By Citron D
Journal of Commercial Biotechnology, Vol. 9, Iss. 1, 2002-09 ,pp. :
Access to resources
Recommend
By Citron D
Journal of Commercial Biotechnology, Vol. 9, Iss. 2, 2003-01 ,pp. :
By Citron David
Journal of Commercial Biotechnology, Vol. 9, Iss. 3, 2003-03 ,pp. :
By Citron David
Journal of Commercial Biotechnology, Vol. 10, Iss. 2, 2003-12 ,pp. :
By Citron David
Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. :